Donate for groundbreaking dendritic cell therapy

Prof Dr Joachim Aerts from the Department of Pulmonary Medicine at Erasmus MC is a leader in immunotherapy research in various types of cancer. His recent study shows that immunotherapy with dendritic cells is not only safe and feasible, but also produces promising results. After two years, 64% of patients had no disease recurrence, an impressive increase from the previous 40%. 

This is a great step, but more research is needed to further increase the effectiveness of this promising therapy. The next step? Loading dendritic cells with small particles, called peptides, to treat asbestos cancer (mesothelioma) more effectively.

The Erasmus MC Foundation asks for your support for the development of this innovative treatment, which is going to have an impact on the lives of many.